Phylos Bioscience, Inc. — Form D/A

Phylos Bioscience, Inc. of PORTLAND, OR, a company, filed a Form D amendment with the SEC on 2020-05-05. The offering totals $26.0M, of which $12.2M was reported sold. Industry: Other.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
Mowgli HolmesDirectorPortland, OR
Lada J Rasochova, PhDDirectorPortland, OR
Mowgli HolmesExecutive OfficerPortland, OR
Nishan KarassikDirectorPortland, OR
Nishan KarassikExecutive OfficerPortland, OR
Nishan KarassikPromoterPortland, OR
Barbara J PeacheyExecutive OfficerPortland, OR
Ralph J RischDirectorPortland, OR
Ralph J RischExecutive OfficerPortland, OR
Timothy J GregoryDirectorPortland, OR
David J PattersonDirectorPortland, OR
Mina J MishrikeyDirectorPortland, OR
Mina MishrikeyDirectorPortland, OR
David A PattersonDirectorPortland, OR
Ralph A RischDirectorPortland, OR
Ralph A RischExecutive OfficerPortland, OR
Barbara A PeacheyExecutive OfficerPortland, OR
Dylan J AndersonExecutive OfficerPortland, OR
Dan ReinerDirectorNewport, WA
Scott J BowmanExecutive OfficerPortland, OR
Mowgli HolmesPromoterPortland, OR
Stephen J LileExecutive OfficerPortland, OR

Other filings by this issuer (20)

Showing 15 of 20 filings.

FiledFormOfferingSold
2025-12-19D$583K
2025-01-23D/A$4.5M
2024-11-01D$4.0M$1.8M
2024-01-24D/A$4.5M
2023-11-07D$150K
2023-02-17D$1.0M$250K
2023-01-26D/A$4.5M
2022-01-24D/A
2021-12-10D
2021-05-05D$5.0M$2.5M
2021-04-19D/A$26.0M$12.2M
2021-01-27D/A$25.0M$4.5M
2020-01-30D$25.0M
2019-05-10D/A$26.0M$2.0M
2019-01-03D$20.0M

More